Publications by authors named "Andrew Schally"

Claim this Profile
E
Evaluation of the Therapeutic Potential of Synthetic Growth Hormone-Releasing Hormone Antagonist MIA-690 as a Cognitive Modulator in a Mouse Model of Gulf War Illness.
Luis Manuel Salgueiro-Tosta, Arumugam Radhakrishnan Jayakumar, William Kochen, Renzhi Cai, Wei Sha, Andrew Victor Schally

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH).
Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Wayne Balkan, Amarylis C B A Wanschel, Konstantinos E Hatzistergos, Andrew V Schally

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach for the treatment of AML, through GHRH antagonism: MIA-602.
Joel Costoya, Simonetta I Gaumond, Ravinder S Chale, Andrew V Schally, Joaquin J Jimenez

Rev Endocr Metab Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone-releasing hormone and cancer.
Iacopo Gesmundo, Francesca Pedrolli, Renzhi Cai, Wei Sha, Andrew V Schally

Rev Endocr Metab Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders.
Andrew V Schally, Renzhi Cai, Xianyang Zhang, Wei Sha, Medhi Wangpaichitr

Rev Endocr Metab Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone-releasing hormone receptor (GHRH-R) and its signaling.
Gabor Halmos, Zsuzsanna Szabo, Nikoletta Dobos, Eva Juhasz, Andrew V Schally

Rev Endocr Metab Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 50-year journey in the development of treatment for benign prostatic hyperplasia.
Andrew V Schally, George Theodoropoulos, Wei Sha, Irving Vidaurre, Medhi Wangpaichitr

NPJ Aging· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth Hormone-Releasing Hormone (GHRH) Antagonist Peptides Combined with PI3K Isoform Inhibitors Enhance Cell Death in Prostate Cancer.
Carlos Perez-Stable, Alicia de Las Pozas, Medhi Wangpaichitr, Wei Sha, Haibo Wang, Andrew V Schally

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.
Iacopo Gesmundo, Francesca Pedrolli, Francesca Romana Giglioli, Florian Jazaj, Giuseppina Granato, Andrew V Schally

Int J Mol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone-releasing hormone and its analogues in health and disease.
Riccarda Granata, Sheila Leone, Xianyang Zhang, Iacopo Gesmundo, Charlotte Steenblock, Andrew V Schally

Nat Rev Endocrinol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Growth hormone-releasing hormone and its analogues in health and disease.
Riccarda Granata, Sheila Leone, Xianyang Zhang, Iacopo Gesmundo, Charlotte Steenblock, Andrew V Schally

Nat Rev Endocrinol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Growth hormone-releasing hormone and its analogues in health and disease.
Riccarda Granata, Sheila Leone, Xianyang Zhang, Iacopo Gesmundo, Charlotte Steenblock, Andrew V Schally

Nat Rev Endocrinol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Aggravating Role of Failing Neuropeptide Networks in the Development of Sporadic Alzheimer's Disease.
Miklós Jászberényi, Balázs Thurzó, Arumugam R Jayakumar, Andrew V Schally

Int J Mol Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Alzheimer type II astrocyte development in hepatic encephalopathy.
Xiao Y Tong, Michael D Norenberg, Michael J Paidas, Nagarajarao Shamaladevi, Luis Salgueiro, Andrew V Schally

Neurochem Int· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers.
Laura Muñoz-Moreno, M Isabel Gómez-Calcerrada, M Isabel Arenas, M José Carmena, Juan C Prieto, Andrew V Schally

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in a Cohort of Hungarian Pediatric Patients with Hematological and Oncological Disorders: A Pilot Study.
Éva Juhász, Zsuzsanna Szabó, Andrew V Schally, József Király, Petra Fodor

Int J Mol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.
Simonetta I Gaumond, Rama Abdin, Joel Costoya, Andrew V Schally, Joaquin J Jimenez

Oncotarget· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age and Sex in the Development of Hepatic Encephalopathy: Role of Alcohol.
Xiao Y Tong, Hussain Hussain, Nagarajarao Shamaladevi, Michael D Norenberg, Aya Fadel, Andrew V Schally

Biology (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.
Jose M Condor Capcha, Ali Kamiar, Emely Robleto, Ali G Saad, Tengjiao Cui, Andrew V Schally

Proc Natl Acad Sci U S A· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of GHRH Deficiency and GHRH Antagonism on Emotional Disorders in Mice.
Lucia Recinella, Maria Loreta Libero, Serena Veschi, Anna Piro, Guya Diletta Marconi, Andrew V Schally

Cells· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.
Giuseppina Granato, Iacopo Gesmundo, Francesca Pedrolli, Ramesh Kasarla, Laura Begani, Andrew V Schally

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signaling mechanism of growth hormone-releasing hormone receptor.
Gabor Halmos, Zsuzsanna Szabo, Eva Juhasz, Andrew V Schally

Vitam Horm· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alveolar epithelial cell growth hormone releasing hormone receptor in alveolar epithelial inflammation.
Tengjiao Cui, Medhi Wangpaichitr, Andrew V Schally, Anthony J Griswold, Irving Vidaurre

Exp Lung Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GHRH agonist MR-409 protects β-cells from streptozotocin-induced diabetes.
Ruy A Louzada, Manuel Blandino-Rosano, Sebastian Flores, Camila Lubaczeuski, Tengjiao Cui, Andrew V Schally

Proc Natl Acad Sci U S A· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Application of GHRH Antagonist as a Treatment for Resistant APL.
Ravinder S Chale, Stephanie M Almeida, Mario Rodriguez, Ivan Jozic, Simonetta I Gaumond, Andrew V Schally

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis